Brief: Biotec Pharmacon Q1 EBITDA Loss Narrows To NOK 3.9 Mln

Arcticzymes Technologies ASA

30/04/2019 06:34

April 30 (Reuters) - Biotec Pharmacon ASA  BIOTEC.OL :
    * BIOTEC PHARMACON Q1 2019 REPORT
    * Q1 GROUP SALES WERE UP 4% TO NOK 14.8 MILLION (Q1 2018:
NOK 14.2
MILLION).
    * Q1  GROSS PROFIT FOR GROUP IMPROVED 23% TO NOK 12.0
MILLION (Q1
2018: NOK 9.7 MILLION) DUE TO IMPROVEMENTS IN ALL HIGH MARGIN
AREAS
    * Q1 EBITDA LOSS NOK 3.9 MILLION VERSUS LOSS NOK 5.1 MILLION
YEAR
AGO

Source text for Eikon:  ID:nObi49MgDa 
Further company coverage:  BIOTEC.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))